You have 9 free searches left this month | for more free features.

Steatohepatitis

Showing 1 - 25 of 1,058

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) Trial in Hialeah Gardens

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Metabolic Dysfunction-associated Steatohepatitis (MASH)
  • Hialeah Gardens, Florida
    Site #430
Nov 1, 2023

Non Alcoholic Steatohepatitis Trial in Tanta (Diosmin, Placebo)

Recruiting
  • Non Alcoholic Steatohepatitis
  • Tanta, Egypt
    Tanta University
Jul 5, 2023

NASH With Fibrosis Trial in Beijing

Not yet recruiting
  • NASH With Fibrosis
    • Beijing, Beijing, China
      Beijing Tsinghua Changgung Hospital
    Nov 3, 2023

    Psoriasis and Non Alcoholic Steatohepatitis: Is ThereShared

    Not yet recruiting
    • Nash
      • (no location specified)
      Aug 15, 2023

      Non-alcoholic Steatohepatitis Trial (Rosuvastatin 20mg, N-acetyl cysteine, Rosuvastatin and N-acetyl cysteine)

      Not yet recruiting
      • Non-alcoholic Steatohepatitis
      • Rosuvastatin 20mg
      • +3 more
      • (no location specified)
      Oct 29, 2023

      Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Taipei, Taiwan
      • +1 more
      Feb 8, 2023

      Nonalcoholic Steatohepatitis With Advanced Fibrosis

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Standard of care
      • Richmond, Virginia
        Virginia Commonwealth University
      Jan 31, 2023

      Non-Alcoholic Steatohepatitis (NASH) Trial in Fort Myers, Sarasota (Pemvidutide, Placebo)

      Recruiting
      • Non-Alcoholic Steatohepatitis (NASH)
      • Fort Myers, Florida
      • +1 more
      Aug 10, 2023

      Non-alcoholic Steatohepatitis Trial (INI-822 (A), Placebo (B))

      Not yet recruiting
      • Non-alcoholic Steatohepatitis
      • INI-822 (A)
      • Placebo (B)
      • (no location specified)
      Jul 6, 2023

      Liver Diseases Trial (Liver Fine-Needle Aspiration)

      Not yet recruiting
      • Liver Diseases
      • Liver Fine-Needle Aspiration
      • (no location specified)
      Nov 29, 2023

      Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

      Not yet recruiting
      • Non-alcoholic Fatty Liver Disease
      • +4 more
      • (no location specified)
      May 17, 2023

      Nonalcoholic Steatohepatitis Trial (Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule)

      Not yet recruiting
      • Nonalcoholic Steatohepatitis
      • Rosuvastatin 20 Mg Oral Tablet
      • Coenzyme Q10 100 MG Oral Capsule
      • (no location specified)
      Feb 7, 2023

      Non Alcoholic Steatohepatitis, Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation Trial in Amsterdam

      Recruiting
      • Non Alcoholic Steatohepatitis
      • +8 more
      • LFMT-capsules
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam UMC
      Apr 6, 2023

      Nonalcoholic Steatohepatitis (NASH) Trial in Guangzhou (ZSP1601, Placebo)

      Not yet recruiting
      • Nonalcoholic Steatohepatitis (NASH)
      • Guangzhou, China
        NanFang Hospital
      Jan 10, 2023

      Nonalcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Tulsa, Waco (HTD1801, Placebo)

      Recruiting
      • Nonalcoholic Steatohepatitis (NASH)
      • Miami Lakes, Florida
      • +2 more
      Jan 13, 2023

      NASH With Fibrosis, Weight Loss, Bariatric Surgery Candidate Trial in Roma (roux -en-y- gastric bypass, intensive life style

      Active, not recruiting
      • NASH With Fibrosis
      • +2 more
      • roux -en-y- gastric bypass
      • intensive life style modification
      • Roma, Italy
        Mingrone Geltrude
      Mar 22, 2023

      Patients With Nonalcoholic Steatohepatitis Trial (Group 1 or Experimental group, Group 2 or Control group)

      Not yet recruiting
      • Patients With Nonalcoholic Steatohepatitis
      • Group 1 or Experimental group
      • Group 2 or Control group
      • (no location specified)
      Nov 14, 2022

      Nonalcoholic Steatohepatitis Trial in Guangzhou (Dapagliflozin, Placebo)

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Guangzhou, Guangdong, China
        Nanfang Hospital of Southern Medical University
      Oct 21, 2022

      Nonalcoholic Steatohepatitis Trial in Rochester (OA-235i (4 mg), OA-235i (8 mg), OA-235i Dose 3)

      Recruiting
      • Nonalcoholic Steatohepatitis
      • OA-235i (4 mg)
      • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 30, 2023

      Nonalcoholic Steatohepatitis (NASH) Trial in Gent (ORMD-0801 QD, ORMD-0801 BD)

      Completed
      • Nonalcoholic Steatohepatitis (NASH)
      • ORMD-0801 QD
      • ORMD-0801 BD
      • Gent, Belgium
        Universitaire Ziekenhuis Gent
      Sep 15, 2022

      NASH - Nonalcoholic Steatohepatitis Trial in San Francisco, Minneapolis (Vertical Sleeve Gastrectomy, Lifestyle Modification

      Recruiting
      • NASH - Nonalcoholic Steatohepatitis
      • Vertical Sleeve Gastrectomy
      • Lifestyle Modification Counseling
      • San Francisco, California
      • +1 more
      Sep 12, 2022

      Non Alcoholic Steatohepatitis Trial in Tanta (Pioglitazone 30mg, Empagliflozin 10 MG)

      Not yet recruiting
      • Non Alcoholic Steatohepatitis
      • Pioglitazone 30mg
      • Empagliflozin 10 MG
      • Tanta, Gharbiya, Egypt
        Tanta University
      Nov 2, 2022

      Nonalcoholic Steatohepatitis

      Recruiting
      • Nonalcoholic Fatty Liver Disease (NAFLD)
      • Nonalcoholic Steatohepatitis (NASH)
      • Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE)
      • Montréal, Quebec, Canada
        Centre Hospitalier de l'Université de Montréal
      Nov 11, 2022

      Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Obesity Trial in United States (HU6, Placebo)

      Not yet recruiting
      • Non-Alcoholic Fatty Liver Disease
      • +3 more
      • Montclair, California
      • +5 more
      Jul 31, 2023

      Non-alcoholic Steatohepatitis Trial in Tanta (Obeticholic Acid Oral Tablet, Vit E)

      Active, not recruiting
      • Non-alcoholic Steatohepatitis
      • Obeticholic Acid Oral Tablet
      • Vit E
      • Tanta, Egypt
        Department of Tropical Medicine and Infectious Diseases, Faculty
      Oct 6, 2022